Healx
Andrew joins Healx from technology giant Dyson, where he was the founding member of the Machine Learning Research Department, leading the research and implementation of machine learning and artificial intelligence across a variety of global product categories. In his time as Director of Machine Learning at Dyson, Andrew also established a new research group, focused on the intersection between machine learning and cutting-edge biomedical research.
Prior to Dyson, Andrew oversaw various innovation projects at security software company Symantec, where he was responsible for - amongst other things - architecting and delivering the world’s largest repository of information security data. He has also led technical teams at GCHQ and is currently undertaking a PhD in Pharmacy and Pharmacology at the University of Bath, with a focus on the pharmacokinetics of topically applied drugs.
This person is not in any offices
Healx
2 followers
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.